WYVERN

Our mission is to develop safe, cost-effective gene therapies that modulate the immune system to address serious unmet treatment needs... Founded in 2017, Wyvern Pharmaceuticals Inc. is a privately held biopharmaceutical company headquartered in Calgary, Canada... We are beginning this journey with a proprietary gene therapy platform to safely and effectively treat serious illnesses, including autoimmune disorders, cancer and infectious diseases.